Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
British Journal of Cancer|October 1, 1987
Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trialF Elferink, W J van der Vijgh, W W ten Bokkel Huinink, et al.British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics and toxicology of sparsomycin in beagle dogsZ Zylicz, D J Wagener, P Fernandez del Moral, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinomaA. P. Kudelka, C. F. Verschraegen, Y. Shen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesM Hidalgo, L L Siu, J Nemunaitis, et al.British Journal of Cancer|December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupK Aabo, M Adams, P Adnitt, et al.Cancer Treatment Reports|May 1, 1979
Adriamycin cardiotoxicity: a survey of 1273 patientsC Praga, G Beretta, P L Vigo, et al.Pageof 7